StockData

Nutex Health Inc. (NUTX) stock

NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3072% below fair value
$174.51+4.81 (+2.83%)

Close on Nov 17, 2026Market cap $1.20BP/E 6.9Yield –

Nutex Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nutex Health's revenue for the twelve months ending Jun 30, 2026 was $846.72M, up 6.9% year over year. For fiscal 2025 it was $875.26M, up 82.4% from the year before. Over ten years it grew 112.1% a year on average. The highest annual figure on record is $875.26M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$875.26M+82.4%
FY2024Dec 31, 2024$479.95M+93.8%
FY2023Dec 31, 2023$247.65M+12.9%
FY2022Dec 31, 2022$219.29M-33.9%
FY2021Dec 31, 2021$331.53M+21.0%
FY2020Dec 31, 2020$274.03M+19954.5%
FY2019Dec 31, 2019$1.37M-0.0%
FY2018Dec 31, 2018$1.37M+5800.9%
FY2017Dec 31, 2017$23.17K–
FY2016Dec 31, 2016$0-100.0%
FY2015Dec 31, 2015$474.68K-55.6%
FY2014Dec 31, 2014$1.07M-26.9%
FY2013Dec 31, 2013$1.46M-8.3%
FY2012Dec 31, 2012$1.59M-10.7%
FY2011Dec 31, 2011$1.78M+103.9%
FY2010Dec 31, 2010$874.77K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$210.75M-13.6%
Q1 FY2026Mar 31, 2026$216.49M+2.2%
Q4 FY2025Dec 31, 2025$151.68M-41.1%
Q3 FY2025Sep 30, 2025$267.80M+239.9%
Q2 FY2025Jun 30, 2025$243.99M+220.7%
Q1 FY2025Mar 31, 2025$211.79M+214.0%
Q4 FY2024Dec 31, 2024$257.62M+269.8%
Q3 FY2024Sep 30, 2024$78.80M+25.6%
Q2 FY2024Jun 30, 2024$76.08M+29.1%
Q1 FY2024Mar 31, 2024$67.45M+19.7%
Q4 FY2023Dec 31, 2023$69.67M+29.7%
Q3 FY2023Sep 30, 2023$62.72M+120.9%
Q2 FY2023Jun 30, 2023$58.92M+1.5%
Q1 FY2023Mar 31, 2023$56.33M-28.8%
Q4 FY2022Dec 31, 2022$53.72M-15.3%
Q3 FY2022Sep 30, 2022$28.40M-75.9%
Q2 FY2022Jun 30, 2022$58.05M-7.6%
Q1 FY2022Mar 31, 2022$79.13M+3828.2%
Q4 FY2021Dec 31, 2021$63.40M-76.8%
Q3 FY2021Sep 30, 2021$117.97M+33603.1%
Q2 FY2021Jun 30, 2021$62.81M+16491.8%
Q1 FY2021Mar 31, 2021$2.01M+332.6%
Q4 FY2020Dec 31, 2020$272.83M+52939.7%
Q3 FY2020Sep 30, 2020$350.03K+79.9%
Q2 FY2020Jun 30, 2020$378.59K-15.0%
Q1 FY2020Mar 31, 2020$465.63K+119.5%
Q4 FY2019Dec 31, 2019$514.40K-61.5%
Q3 FY2019Sep 30, 2019$194.61K+761.8%
Q2 FY2019Jun 30, 2019$445.28K+11850.6%
Q1 FY2019Mar 31, 2019$212.14K+4960.5%
Q4 FY2018Dec 31, 2018$1.34M+28985.9%
Q3 FY2018Sep 30, 2018$22.58K+419.1%
Q2 FY2018Jun 30, 2018$3.73K–
Q1 FY2018Mar 31, 2018$4.19K–
Q2 FY2017Jun 30, 2017$4.60K–
Q1 FY2017Mar 31, 2017$4.35K–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–
Q2 FY2016Jun 30, 2016$0–

More Nutex Health figures

See a number that looks wrong?